Loading...
Secondary Chemoprevention of Barrett’s Esophagus With Celecoxib: Results of a Randomized Trial
BACKGROUND: Barrett’s esophagus is a premalignant condition that is a risk factor for the development of esophageal adenocarcinoma, a disease whose incidence is rapidly increasing. Because aspirin and other nonsteroidal antiinflammatory drugs, such as celecoxib, may decrease the risk of developing e...
Na minha lista:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2007
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3755596/ https://ncbi.nlm.nih.gov/pubmed/17405999 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djk112 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|